8-K: Inspire Medical Systems Announces Retirement of Long-Serving Board Member, Dr. Jerry C. Griffin

Inspire Medical Systems announced the retirement of Dr. Jerry C. Griffin from its Board of Directors after sixteen years of service, effective at the conclusion of the 2024 Annual Meeting of Stockholders.

Summary

• Inspire Medical Systems has announced the retirement of Dr. Jerry C. Griffin from its Board of Directors.
• Dr. Griffin's retirement will be effective at the conclusion of the company's 2024 Annual Meeting of Stockholders, scheduled for May 2, 2024.
• Dr. Griffin has served on the board since 2008 and was one of the original board members.
• The company acknowledges Dr. Griffin's significant contributions to the board and organization.
• Inspire Medical Systems has grown to treat over 60,000 patients, employ one thousand people, and generate $600 million in annual revenue during Dr. Griffin's tenure.
• In December 2023, the company appointed Dr. Myriam J. Curet to the board.

Sentiment

Score: 7

Explanation: The document is generally positive, highlighting the company's growth and acknowledging the contributions of a long-serving board member. The retirement is planned and orderly, and the appointment of a new board member is a positive development. There are no negative surprises.

Positives

• Dr. Griffin's long service and contributions to the company are acknowledged.
• The company has experienced significant growth during Dr. Griffin's tenure, including treating over 60,000 patients and reaching $600 million in annual revenue.
• The appointment of Dr. Myriam J. Curet to the board in December 2023 adds another experienced medical device executive.

Risks

• The document contains forward-looking statements which involve inherent risks and uncertainties.
• Actual results could differ materially from those anticipated due to various factors.

Future Outlook

The company's future performance is subject to risks and uncertainties, as detailed in their SEC filings.

Management Comments

• Tim Herbert, President and Chief Executive Officer of Inspire Medical Systems, stated that Dr. Griffin's contributions to the Board and organization are innumerable.
• Tim Herbert personally thanked Jerry for his years at Inspire, his invaluable expertise, guidance and partnership.

Industry Context

This announcement is a routine corporate governance update for a medical technology company. The appointment of a new board member with experience at Intuitive Surgical suggests a focus on innovation and growth in the medical device sector.

Comparison to Industry Standards

• The appointment of Dr. Curet, an executive from Intuitive Surgical, a leader in robotic surgery, suggests Inspire is aiming to align with industry best practices in medical device innovation and governance.
• The growth of Inspire to $600 million in annual revenue and 1000 employees is a significant achievement, placing it among the successful mid-sized medical device companies.
• The company's focus on minimally invasive solutions for obstructive sleep apnea aligns with the broader trend in healthcare towards less invasive procedures.

Management Changes

Stakeholder Impact

• Shareholders may view the orderly transition of board members as a sign of good corporate governance.
• Employees may see the company's growth and stability as positive for their job security.
• Customers and patients may not be directly impacted by this change.

Next Steps

• Dr. Griffin's retirement will be effective at the conclusion of the 2024 Annual Meeting of Stockholders on May 2, 2024.
• The company will likely nominate a new board member to replace Dr. Griffin.

Key Dates

Keywords

Board of Directors, Retirement, Medical Technology, Obstructive Sleep Apnea, Neurostimulation, Corporate Governance, Annual Meeting, Medical Device